 Antibodies, Monoclonal
"Antibodies, Monoclonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies produced by a single clone of cells.
| Descriptor ID |
D000911
|
| MeSH Number(s) |
D12.776.124.486.485.114.224 D12.776.124.790.651.114.224 D12.776.377.715.548.114.224
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Monoclonal".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Monoclonal".
This graph shows the total number of publications written about "Antibodies, Monoclonal" by people in this website by year, and whether "Antibodies, Monoclonal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 1 | 1 | | 1982 | 0 | 3 | 3 | | 1983 | 5 | 6 | 11 | | 1984 | 4 | 4 | 8 | | 1985 | 1 | 4 | 5 | | 1986 | 0 | 12 | 12 | | 1987 | 3 | 8 | 11 | | 1988 | 4 | 4 | 8 | | 1989 | 4 | 10 | 14 | | 1990 | 2 | 7 | 9 | | 1991 | 5 | 11 | 16 | | 1992 | 3 | 11 | 14 | | 1993 | 9 | 12 | 21 | | 1994 | 2 | 14 | 16 | | 1995 | 1 | 15 | 16 | | 1996 | 7 | 12 | 19 | | 1997 | 6 | 7 | 13 | | 1998 | 11 | 6 | 17 | | 1999 | 7 | 11 | 18 | | 2000 | 5 | 13 | 18 | | 2001 | 12 | 10 | 22 | | 2002 | 13 | 15 | 28 | | 2003 | 17 | 21 | 38 | | 2004 | 13 | 10 | 23 | | 2005 | 8 | 7 | 15 | | 2006 | 13 | 6 | 19 | | 2007 | 13 | 5 | 18 | | 2008 | 6 | 12 | 18 | | 2009 | 9 | 7 | 16 | | 2010 | 5 | 9 | 14 | | 2011 | 3 | 4 | 7 | | 2012 | 9 | 9 | 18 | | 2013 | 15 | 6 | 21 | | 2014 | 6 | 3 | 9 | | 2015 | 7 | 4 | 11 | | 2016 | 7 | 2 | 9 | | 2017 | 2 | 0 | 2 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Monoclonal" by people in Profiles.
-
Behere K, Cha B, Yoon S. Protein a resin lifetime study: Evaluation of protein a resin performance with a model-based approach in continuous capture. Prep Biochem Biotechnol. 2018 Mar 16; 48(3):242-256.
-
Holman N, Weinfurter JT, Harsla TR, Wiseman RW, Belli AJ, Michaels AJ, Reimann KA, DeMars RI, Reynolds MR. Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001. PLoS One. 2017; 12(7):e0179039.
-
Usmani SZ, Diels J, Ito T, Mehra M, Khan I, Lam A. Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison. Am J Hematol. 2017 Aug; 92(8):E146-E152.
-
Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S. Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar; 16(3):189-199.
-
Jacobs RW, Awan FT, Leslie LA, Usmani SZ, Ghosh N. The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia. Expert Rev Hematol. 2016 Dec; 9(12):1177-1187.
-
Dimopoulos MA, Oriol A, Nahi H, San-Miguel J, Bahlis NJ, Usmani SZ, Rabin N, Orlowski RZ, Komarnicki M, Suzuki K, Plesner T, Yoon SS, Ben Yehuda D, Richardson PG, Goldschmidt H, Reece D, Lisby S, Khokhar NZ, O'Rourke L, Chiu C, Qin X, Guckert M, Ahmadi T, Moreau P. Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2016 10 06; 375(14):1319-1331.
-
Turner PL, Barry KA. Alirocumab (Praluent) for Treatment of Hyperlipidemia. Am Fam Physician. 2016 Aug 15; 94(4):310-1.
-
Saphire EO, Aman MJ. Feverish Quest for Ebola Immunotherapy: Straight or Cocktail? Trends Microbiol. 2016 09; 24(9):684-686.
-
Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, Le DT, Lipson EJ, Glezerman IG, Wolchok J, Cornell LD, Feldman P, Stokes MB, Zapata SA, Hodi FS, Ott PA, Yamashita M, Leaf DE. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016 09; 90(3):638-47.
-
Usmani SZ, Weiss BM, Plesner T, Bahlis NJ, Belch A, Lonial S, Lokhorst HM, Voorhees PM, Richardson PG, Chari A, Sasser AK, Axel A, Feng H, Uhlar CM, Wang J, Khan I, Ahmadi T, Nahi H. Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma. Blood. 2016 07 07; 128(1):37-44.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|